Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
Cellular Signalling|January 11, 2017
The cyclic AMP phosphodiesterase 4D5 (PDE4D5)/receptor for activated C-kinase 1 (RACK1) signalling complex as a sensor of the extracellular nano-environmentStephen J Yarwood, Euan Parnell, Rebecca J BirdTrends in Pharmacological Sciences|March 7, 2015
The future of EPAC-targeted therapies: agonism versus antagonismEuan Parnell, Timothy M Palmer, Stephen J YarwoodMolecular and Cellular Endocrinology|July 31, 1998
Cyclic AMP potentiates growth hormone-dependent differentiation of 3T3-F442A preadipocytes: possible involvement of the transcription factor CREBS J Yarwood, E Kilgour, N G AndersonBiochemical and Biophysical Research Communications|July 25, 1996
Cyclic AMP stimulates the phosphorylation and activation of p42 and p44 mitogen-activated protein kinases in 3T3-F442A preadipocytesS J Yarwood, E Kilgour, N G AndersonBiochemical Society Transactions|January 21, 2012
Novel control of cAMP-regulated transcription in vascular endothelial cellsGillian R Milne, Timothy M Palmer, Stephen J YarwoodThe Biochemical Journal|September 8, 2010
Interaction with receptor for activated C-kinase 1 (RACK1) sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase CRebecca J Bird, George S Baillie, Stephen J YarwoodBiochemical and Biophysical Research Communications|February 27, 2004
Protease inhibitors prevent the protein kinase A-dependent loss of Rap1 GTPase from the particulate fraction of COS1 cellsCatherine J Rundell, Claire E Repellin, Stephen J YarwoodJournal of Pharmaceutical and Biomedical Analysis|January 1, 1987
The influence of the ammonium ion on the stability of ethacrynic acid in aqueous solutionR J Yarwood, W D Moore, J H CollettThe EMBO Journal|December 1, 1984
Human globin gene transcription in injected Xenopus oocytes: enhancement by sodium butyrateG A Partington, N J Yarwood, T R RutherfordNeuropeptides|February 1, 1996
Probing the V1a vasopressin receptor binding site with pyroglutamate-substituted linear antagonistsJ Howl, N J Yarwood, D Stock, et al.Pageof 8